| Literature DB >> 28391410 |
G Budryn1, D Zaczyńska2, D Żyżelewicz2, J Grzelczyk2, Z Zduńczyk3, J Juśkiewicz3.
Abstract
Green coffee is one of health-promoting supplements of the diet, applied in the form of either preparations or enriched food products. Its positive impact is manifested by mitigation of the development of certain tumors, e.g., in the colon and liver, and type 2 diabetes. Many studies proved that chlorogenic acids are the main active substances in green coffee. The bioavailability of these compounds depends among others on their interactions with other components of the diet, mainly proteins. When they are used as food ingredients, their bioavailability is additionally decreased because of the decomposition or interactions with other ingredients during food processing. The undesirable changes may be limited among others by microencapsulation, for example with β-cyclodextrin. In this study, rats were fed the pro-oxidative high fat diet, which was supplemented with chlorogenic acids from green coffee that were used in four forms such as: a purified extract, complexes of chlorogenic acids and β-cyclodextrin, and bread supplemented with either the extract or the β-cyclodextrin inclusion complex. Chlorogenic acids added to bread because of the reduced absorption from the crumb in the small intestine and increased passage to the colon, contributed to the beneficial modification of enzymatic activities of intestinal microbiota. When added directly to the diet, they contributed to the improved antioxidant status in the liver and kidneys, lowered glucose level and increased HDL level. A high ratio of reduced to oxidized glutathione in the liver and a high concentration of antioxidants in the blood serum were observed after administration of chlorogenic acids in the form of inclusion complexes with β-cyclodextrin, indicating that microencapsulation increased their bioaccessibility due to the limited interactions with other components of the diet.Entities:
Keywords: Chlorogenic acids; Green coffee; Rat model; β-cyclodextrin
Mesh:
Substances:
Year: 2017 PMID: 28391410 PMCID: PMC5486897 DOI: 10.1007/s11130-017-0608-3
Source DB: PubMed Journal: Plant Foods Hum Nutr ISSN: 0921-9668 Impact factor: 3.921
Formulation of bread supplemented with CGAs (g/100 g of the final product)
| Ingredient | CB | BGCE | BβCD-CGAs |
|---|---|---|---|
| Wheat flour | 50.0 | 48.7 | 47.1 |
| Yeast | 5.0 | 5.0 | 5.0 |
| Sugar | 1.0 | 1.0 | 1.0 |
| Salt | 0.7 | 0.7 | 0.7 |
| Water | 43.3 | 43.3 | 43.3 |
| Green coffee extract | - | 1.3 | - |
| β-CD-CGAs inclusion complex | - | - | 2.9 |
CGAs–Chlorogenic acids; CB Control bread without additives; BGCE Bread supplemented with chlorogenic acids in the form of green coffee extract; BβCD-CGAs Bread supplemented with chlorogenic acids in the form of inclusion complexes with β-cyclodextrin
Body weight, diet intake, body composition and indices of the cecum and colon in rats
| Index | C | CF | FGCE | FβCD-CGAs | CB | BGCE | BβCD-CGAs | SEM |
|
|---|---|---|---|---|---|---|---|---|---|
| Initial body weight (g) | 280a | 280a | 280a | 280a | 281a | 281a | 281a | 1.301 | 0.091 |
| Final body weight (g) | 364a | 392 | 379 | 384 | 365a | 365a | 364a | 2.089 | 0.076 |
| Body weight gain (g) | 84a | 112 | 99 | 104 | 84a | 84a | 83a | 1.626 | 0.065 |
| Diet intake (g/day) | 19.7d | 19.2b | 19.6c,d | 18.7a | 19.3b | 19.4b,c | 18.6a | 0.144 | 0.082 |
| Fat mass (g) | 123.8a | 148.5 | 132.0 | 145.3 | 123.6 | 123.3a | 115.3 | 1.536 | 0.180 |
| Lean mass (g) | 128.0 | 125.2 | 126.0 | 127.3 | 128.7 | 129.2 | 140.8 | 1.732 | 0.134 |
| Cecum: | |||||||||
| Tissue1 | 0.254a | 0.199 | 0.272b | 0.257a | 0.276b | 0.299 | 0.359 | 0.009 | 0.103 |
| Contents1 | 0.460 | 0.403 | 0.484 | 0.572 | 0.502 | 0.725 | 1.010 | 0.051 | 0.201 |
| NH3 (mg/g) | 0.320 | 0.339 | 0.285a | 0.298b | 0.299b | 0.284a | 0.275 | 0.007 | 0.125 |
| pH of contents | 7.25 | 7.26 | 7.14 | 7.26 | 7.23 | 6.97 | 6.93 | 0.036 | 0.208 |
| Colon: | |||||||||
| Tissue1 | 0.267a,b | 0.264a | 0.271b | 0.299c | 0.295c | 0.272b | 0.284 | 0.005 | 0.199 |
| Contents1 | 0.190a | 0.184 | 0.190a | 0.207 | 0.197 | 0.218 | 0.235 | 0.013 | 0.287 |
| pH of contents | 6.85b | 6.83b | 6.59a | 6.57a | 6.83b | 6.68 | 6.49 | 0.048 | 0.019 |
C Control diet; CF Control high fat diet; FGCE High fat diet supplemented with chlorogenic acids in the form of green coffee extract; FβCD-CGAs High fat diet supplemented with chlorogenic acids in the form of inclusion complexes with β-cyclodextrin; CB Control diet with bread without additives; BGCE Diet with bread supplemented with chlorogenic acids in the form of green coffee extract; BβCD-CGAs Diet with bread supplemented with chlorogenic acids in the form of inclusion complexes with β-cyclodextrin; SEM Summed standard error; n = 56; 1 g/100 g of body weight (BW); the same letter in one line means no significant differences (P > 0.05)
The activity of some bacterial enzymes in the faeces of rats during the experiment
| Enzyme | C | CF | FGCE | FβCD-CGAs | CB | BGCE | BβCD-CGAs | SEM |
|
|---|---|---|---|---|---|---|---|---|---|
| β-glucosidase | |||||||||
| Day 0 | 47.6 | 46.5a | 48.2 | 46.5a | 46.3 | 45.6a | 45.2 | 1.632 | 0.074 |
| Day 4 | 21.4 | 29.0 | 20.3 | 17.7 | 26.2 | 11.9 | 10.9 | 1.765 | 0.097 |
| Day 8 | 18.4 | 21.4a | 15.5 | 12.3 | 22.4a | 8.0 | 5.3 | 1.362 | 0.081 |
| Day 11 | 14.7 | 18.2 | 7.2a | 7.1a | 15.9 | 5.7 | 4.3 | 0.856 | 0.116 |
| β-galactosidase | |||||||||
| Day 0 | 76.8b | 76.8b | 77.2 | 76.9b | 76.4a | 76.4a | 74.1 | 0.885 | 0.095 |
| Day 4 | 65.7 | 138.0 | 130.7 | 111.4 | 66.7 | 41.2 | 38.5 | 3.095 | 0.125 |
| Day 8 | 56.1 | 127.3 | 119.2 | 97.8 | 61.0 | 25.5 | 23.4 | 3.497 | 0.041 |
| Day 11 | 48.8 | 113.1 | 96.3 | 76.6 | 45.1 | 27.6 | 25.4 | 2.504 | 0.023 |
| β-glucuronidase | |||||||||
| Day 0 | 38.1c | 37.0a,b | 36.8a | 37.3b | 39.5c | 38.0 | 36.9a | 2.100 | 0.072 |
| Day 4 | 49.2 | 75.3 | 56.3 | 51.2 | 47.1 | 35.5 | 30.7 | 3.279 | 0.008 |
| Day 8 | 20.8 | 69.9 | 37.2 | 22.9 | 29.5 | 14.7 | 10.1 | 2.086 | 0.075 |
| Day 11 | 14.0 | 55.8 | 27.2 | 22.0 | 18.2 | 8.9a | 8.8a | 1.291 | 0.124 |
SEM Summed standard error; n = 56; μmol/h/g faeces; the same letter in one line means no significant differences (P > 0.05); for abbreviations of diets see the descriptions under Table 2
Concentration of volatile short chain fatty acids (SCFA) in the contents of the cecum in rats
| Fatty acid | C | CF | FGCE | FβCD-CGAs | CB | BGCE | BβCD-CGAs | SEM |
|
|---|---|---|---|---|---|---|---|---|---|
| Acetic acid | 32.4 | 38.2 | 41.0 | 43.4 | 38.8 | 45.7 | 46.6 | 1.973 | 0.003 |
| Propionic acid | 12.5 | 7.1 | 14.8 | 17.2 | 12.0 | 16.5 | 19.7 | 0.510 | 0.009 |
| Iso-butyric acid | 4.0c,d | 3.9c | 3.1b | 3.0b | 4.2d | 2.8a | 2.8a | 0.127 | 0.043 |
| Butyric acid | 3.5 | 2.1 | 4.7 | 5.0 | 3.2 | 5.3a | 5.4a | 0.218 | 0.003 |
| Iso-valeric acid | 2.3c | 2.6 | 2.1c | 1.5a | 1.7b | 1.4a,b | 1.2 | 0.090 | 0.034 |
| Valeric acid | 1.9 | 2.1 | 1.2 | 0.8a | 0.8a | 0.6a | 0.5a | 0.047 | 0.001 |
| PSCFA | 8.2 | 8.6 | 6.4 | 5.3 | 6.7 | 4.8 | 4.5 | 0.211 | 0.306 |
| SCFA Total | 56.6 | 56.0 | 66.9 | 70.9 | 60.7 | 72.3 | 76.2 | 2.635 | 0.004 |
SEM Summed standard error, n = 56; PSCFA Putrefactive volatile fatty acids (sum of iso-butyric, iso-valeric and valeric acids); μmol/g of cecum content; the same letter in one line means no significant differences (P > 0.05); for abbreviations of diets see the descriptions under Table 2
Selected indices associated with metabolic syndrome in rats blood serum
| Index | C | CF | FGCE | FβCD-CGAs | CB | BGCE | BβCD-CGAs | SEM |
|
|---|---|---|---|---|---|---|---|---|---|
| Glucose (mmol/L) | 11.5a | 11.8b | 10.8 | 11.1 | 11.5a | 11.7b | 11.7b | 0.198 | 0.062 |
| TG (mmol/L) | 0.64b | 0.67c | 0.64b | 0.61 | 0.66c | 0.58a | 0.57a | 0.022 | 0.081 |
| TC (mmol/L) | 1.31 | 1.58b | 1.34a | 1.59b | 1.33a | 1.38 | 1.50 | 0.037 | 0.124 |
| HDL (mmol/L) | 0.53a | 0.54a | 0.59b | 0.66 | 0.53a | 0.58b | 0.64 | 0.014 | 0.026 |
| non-HDL (mmol/L) | 0.78a | 1.04 | 0.75 | 0.93 | 0.80a | 0.80a | 0.86 | 0.027 | 0.174 |
| Uric acid (μmol/L) | 41.3 | 36.6a | 32.8 | 36.0 | 41.8 | 34.5 | 36.4a | 1.256 | 0.113 |
| Creatynine (μmol/L) | 23.2b,c | 23.1b | 19.4 | 19.7a | 23.4c | 18.8 | 19.6a | 0.986 | 0.076 |
| Urea (mmol/L) | 5.03 | 4.30 | 3.64 | 4.12a,b | 4.17c | 4.08a | 4.15b,c | 0.147 | 0.050 |
| AST (U/L) | 75.0a | 82.7 | 77.9 | 80.6 | 75.1a | 71.9 | 73.1 | 1.653 | 0.099 |
| ALT (U/L) | 25.3 | 27.1 | 21.4 | 24.0 | 21.8 | 20.1 | 20.8 | 0.610 | 0.111 |
SEM Summed standard error, n = 56; TG Triglycerides; TC Total cholesterol; HDL-HDL Cholesterol; AST Aspartate aminotransferase; ALT Alanine aminotransferase; the same letter in one line means no significant differences (P > 0.05); for abbreviations of diets see the descriptions under Table 2
Antioxidant indices in the internal organs and blood serum in rats
| Index | C | CF | FGCE | FβCD-CGAs | CB | BGCE | BβCD-CGAs | SEM |
|
|---|---|---|---|---|---|---|---|---|---|
| Serum | |||||||||
| ACW (μg/mL) | 1.59a | 1.52 | 1.75 | 1.97 | 1.57a | 1.70 | 2.09 | 0.075 | 0.051 |
| ACL (μg/mL) | 1.51a,b | 1.50a | 2.19 | 4.97 | 1.54b | 1.85 | 4.30 | 0.262 | 0.101 |
| Heart | |||||||||
| Weight (g/100 g BW) | 0.255a | 0.268b | 0.255a | 0.265b | 0.255a | 0.249 | 0.242 | 0.003 | 0.176 |
| TBARS | 781 | 827a | 794 | 826a | 801 | 705 | 789 | 27.45 | 0.126 |
| Kidney | |||||||||
| Weight (g/100 g BW) | 0.582b | 0.545a | 0.570c | 0.547a | 0.586b | 0.564c | 0.606 | 0.007 | 0.023 |
| TBARS | 1186 | 1248 | 1104 | 1138 | 1154 | 1125 | 1167 | 12.38 | 0.192 |
| Liver | |||||||||
| Weight (g/100 g BW) | 2.78b,c | 2.81c | 2.62 | 2.78b,c | 2.76a,b | 2.70 | 2.75a | 0.025 | 0.117 |
| TBARS | 708 | 770 | 722 | 672 | 704 | 756 | 746 | 10.63 | 0.105 |
| GSH (μmol/g) | 16.8a | 10.0 | 19.5b | 12.7 | 16.9a | 19.9c | 19.6b,c | 0.478 | 0.081 |
| GSSG (μmol/g) | 5.82a | 5.46 | 2.91 | 5.84a | 5.96 | 6.33 | 5.57 | 0.199 | 0.107 |
| GSH/GSSG | 2.89a | 1.83 | 6.70 | 2.17 | 2.84a | 3.14 | 3.52 | 0.127 | 0.031 |
SEM Summed standard error, n = 56; TBARS Content of substances reacting with thiobarbituric acid, ng/g tissue; ACW/ACL The antioxidant capacity derived from hydrophilic/lipophilic antioxidants; the same letter in one line means no significant differences (P > 0.05); for abbreviations of diets see the descriptions under Table 2